Request a meeting with Forge at Phacilitate Advanced Therapies Week in Miami January 25-28!
Dedicated to AAV Manufacturing
Blaze Vector Production™
Turnkey, scalable, premier research-grade AAV production.
Our proprietary Ignition Cells™ with open licensing and royalty-free usage
Established process for many standard AAV serotypes
Upfront communication and pricing
Fast turnaround time
Process & Analytical Development
End-to-end capabilities from research to cGMP grade, reducing the need for bridging studies.
Experienced team able to support process development and scale up
In-house analytical assay development and performance to support cGMP-readiness
Production of toxicology material
Process development to manufacture novel engineered capsids
cGMP Production
Fully disposable, closed-system processing.
Flexible scheduling and maximization of capacity
Consistent process and product flow for reduction of variation
Changing the dynamic of manufacturing for gene therapies.
Our Advanced Technologies
The Forge Plasmid Transfection Model
Ignition Cells™
Royalty-free license for clients
Clonal HEK293 suspension cell line
Well documented history for clinical to commercial use
Optimized for robust transient transfection
Animal component free
Scalable production
pEMBR™ Adenovirus Helper Plasmid
Custom designed smaller ad helper plasmids Lower cost for production Improved safety profile – removed unnecessary adenoviral elements Forge Biologics intellectual property Available for pipeline use
Forging a path forward for gene therapy
Our mission is to enable access to life changing gene therapies and help bring them from idea into reality. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them the most.
